Mithra Signs License and Supply Agreement for Commercialization of Tibelia® in Italy

  • Mithra grant a license to Farmitalia for commercialization of its hormone treatment Tibelia® in Italy
  • Tibelia® is currently marketed in 13 countries through existing license and supply agreements
Liege, Belgium, 07 January 2020 – 7 :30 CET – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces that it has entered into a license and supply agreement with Farmitalia for the commercialization of Tibelia® in Italy.